Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 12, 2021 at 05:11 pm
Share
Easywell Biomedicals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 46.525 million compared to TWD 67.791 million a year ago. Operating loss was TWD 62.430 million compared to TWD 52.485 million a year ago. Net loss was TWD 61.442 million compared to TWD 54.330 million a year ago. Basic loss per share was TWD 0.43 compared to TWD 0.42 a year ago. For the half year, sales was TWD 118.164 million compared to TWD 145.627 million a year ago. Operating loss was TWD 116.110 million compared to TWD 97.729 million a year ago. Net loss was TWD 56.385 million compared to TWD 100.121 million a year ago. Basic loss per share was TWD 0.4 compared to TWD 0.79 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
EASYWELL BIOMEDICALS, INC. 